Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

 Daifulah ALZahrani

Daifulah ALZahrani

King Saud Bin Abdulaziz University for Health Sciences, United Arab Emirates

Tian Yuyao

Tian Yuyao

University of HongKong, Hong Kong

Kiss T.Freeman

Kiss T.Freeman

University of Liberia, Finland

Hend M. El Tayebi

Hend M. El Tayebi

German University, Egypt

Recommended Global Nursing Webinars & Conferences

Europe & UK
Asia Pacific & Middle East

Dementia 2021

About us

Conference Series welcomes every one of the members across the world to go to International Conference on Dementia and Alzheimer sickness to be held during  October 20-21, 2021 in Zurich , Switzerland  time region which incorporates brief feature introductions, Oral talks, e-Poster introductions, Young Research Forum(YRF) and Exhibitions.
For what reason to join in?
The Dementia 2021 speaks with people across the globe focused in on getting some answers concerning cautious and its qualities. This is the most perfect opportunity to show up at the greatest individuals. Sharing the data and displays, information and B2B social events with industrialists and anticipated that customers should make a sprinkle with innovative things live and brand affirmation at this event. Extraordinarily celebrated speakers, the most recent methodologies, and the latest degrees of progress in Dementia are indications of this gathering
Target Audience:
  • Neurologists and Directors
  • Physicians
  • Neuroscientists
  • Specialists
  • researchers
  • Health care professionals
  • Professors
  • Industrial Experts
  • Neurosurgeons
  • Psychiatrist
  • Nutritional Scientists
  • Lecturers and Students from Academia in the study of Dementia


Scientific Sessions

Scientific Session 1:  Dementia
Dementia may be a constant or diligent issue of the psychological volume unit caused by cerebrum sicknesses or wounds set apart due to character changes, memory problems and disabled thinking. Dementia is anything but a particular infection. It's a gathering of manifestations related with a decrease in memory or other reasoning capacity abilities enough to diminish an individual's capacity exercises. Different sorts of dementia are related with specific sorts of synapse harm specifically districts of the cerebrum
Scientific Session 2 : Vascular Dementia
Vascular dementia, which happens following a stroke, is the second most regular dementia type. However, there are numerous different conditions which will cause manifestations of dementia, including some that are reversible, like thyroid issues and nutrient inadequacies. In vascular dementia, changes in reasoning abilities now and again happen unexpectedly following strokes that square significant mind veins. Thinking issues likewise may start as gentle changes that deteriorate progressively due to various minor strokes or different conditions that influence smaller veins, prompting total harm
Scientific Session 3: Alzheimers Disease
Alzheimer's disease is irreversible and decimates cerebrum cells, making thinking capacity and memory weaken. Alzheimer's infection is a dynamic, degenerative mind ailment and the most widely recognized type of dementia, a gathering of brain disorders that influence a man's memory, considering and capacity to connect socially. Dementia and Alzheimer's infection isn’t the same. Dementia is a general term used to depict indications that effect memory, execution of day by day exercises, and correspondence capacities. Alzheimer's infection is the most widely recognized kind of dementia.
Scientific Session 4 : Dementia stages
Dementia in "stages," alludes how far a person's dementia has been advanced. It characterizes a person's infection stage assisting doctors with deciding the simplest treatment approach and help correspondence between wellbeing suppliers and parental figures. Here and there the stage is actually alluded to as "beginning phase", "center stage" or "late-stage" dementia, however regularly a more accurate stage is allocated, in light of a person's indications.
Scientific Session 5 : Dementia with Lewy Body (DLB)
Individuals with Lewy body dementia have a reformist decrease in their memory and capacity to think; like Alzheimer's infection. In any case, the psychological capacity or readiness of an individual with Lewy body dementia is bound to change starting with one second then onto the next, which isn't care for Alzheimer's sickness. They additionally frequently have visual pipedreams (seeing things that aren't there) and fancies (accepting some falsehood). By all accounts, individuals with Lewy body dementia frequently have issues with development that take after Parkinson's infection. This is on the grounds that similar designs of the cerebrum are influenced in Lewy body dementia and Parkinson's infection.
Scientific Session 6 : Neurodegenerative Diseases
Neurodegenerative sickness essentially influences the neurons in the human cerebrum. Neurons are the structure squares of the sensory system which incorporates the mind and spinal line. Neurons regularly don't replicate or supplant themselves, so when they become harmed or pass on they can't be supplanted by the body. Neurodegenerative sicknesses are serious and weakening conditions that bring about reformist degeneration and/or demise of nerve cells.  Dementias are liable for the best weight of neurodegenerative infections, with Alzheimer's addressing roughly 60-70% of dementia cases.
Scientific Session 7: Mind Diseases
The mind is the control focus of the body. It controls contemplations, memory, discourse, and development. It manages the capacity of numerous organs. At the point when the cerebrum is solid, it works rapidly and naturally. Be that as it may, when issues happen, the outcomes can be destroying. Irritation in the mind can prompt issues like vision misfortune, shortcoming and loss of motion. Loss of synapses, which occurs on the off chance that you endure a stroke, can influence your capacity to think plainly. 
Scientific Session 8 : Parkinson Disease Dementia
Parkinson's sickness (PD) is an age-related degenerative problem of certain synapses. It essentially influences developments of the body, yet different issues, including dementia, may happen. It isn't viewed as an inherited infection, albeit a hereditary connection has been recognized in few families. Sadness, nervousness, character and conduct changes, rest unsettling influences, and sexual issues are normally connected with Parkinson's sickness. As a rule, Parkinson's infection doesn't influence an individual's capacity to think, reason, learn, or recall (psychological cycles).
Scientific Session 9 : Neuropharmacology
Neuropharmacology is the logical investigation of the impacts of medications on the sensory system. Its essential center is the activities of meds for mental and neurologic problems just as those of medications of misuse. Medications that follow up on the sensory system, including energizer, antianxiety, anticonvulsant, and antipsychotic specialists, are among the most generally endorsed drugs.
Scientific Session 10: Neuro Oncology and CNS
Neuro-oncology is the investigation of mind and spinal line neoplasms, a considerable lot of which are extremely perilous and dangerous (astrocytoma, glioma, glioblastoma multiforme, ependymoma, pontine glioma, and cerebrum stem tumors are among the numerous instances of these). Among the harmful mind tumors, gliomas of the brainstem and pons, glioblastoma multiforme, and high-grade (profoundly anaplastic) astrocytoma are among the most exceedingly awful.
The CNS comprises of the cerebrum and spinal line. The mind is ensured by the skull (the cranial pit) and the spinal rope goes from the rear of the cerebrum, down the focal point of the spine, halting in the lumbar area of the lower back. The cerebrum and spinal string are both housed inside a defensive triple-layered film called the meninges.
Geriatrics or geriatric medication could also be a specialty that focuses on health care of older people. It aims to push health by preventing and treating diseases and disabilities in older adults. there is no set age at that patients also are underneath the care of a specialist or geriatric.
Scientific Session12Clinical Trials and Drug Development
Thorough clinical preliminaries on Dementia drugs are proceeding in USA and UK under the direction of Alzheimer's general public and it is accounted for that there is less support of individuals. The majority of medications are in second and third stages. The greater part of clinical preliminaries are done in explicit territories are amyloid beta plaques, the resistant framework, tau tangles. New drugs for Dementia being created in 2014/2015, 31% were named side effects adjusting. There are numerous advancements are going on in Drug disclosure of Dementia as old medicines can't stop the movement of Dementia. Most affiliations share their investigation on new drugs for Dementia in Dementia gatherings to get higher regard to their things. This will be unmistakably profitable to various geriatric specialists to update themselves with such prescriptions and advancing prospects by going to Dementia meetings.
Molecular biological research has considerably deepened our understanding of the pathophysiological basis of Alzheimer's dementia. Considerable progress has been made in our understanding of the genetics and molecular biology of dementia. Some genetic risk factors have been identified so far, but only a small proportion of AD cases can be explained by specific gene mutations. Genes may be related to disease in two ways: through autosomal-dominant mutations, in themselves sufficient to cause the disease alternatively, gene variations (polymorphisms) may indirectly increase disease risk without being sufficient in themselves to cause the disorder.
Scientific Session 14 : Neuroimaging Biomarker
Alzheimer's disease Biomarkers, with emphasis on cerebrospinal fluid biomarkers of Neuroimaging-biomarkers allow an early diagnosis in preclinical stages of Alzheimer’s disease. Biomarker changes in patients with late-onset AD, including findings from studies using structural and functional magnetic resonance imaging (MRI), advanced MRI techniques (diffusion tensor imaging, magnetic resonance spectroscopy, perfusion), positron emission tomography with fluorodeoxyglucose, amyloid tracers, and other neurochemical tracers, and CSF protein levels. The dynamic measures of these imaging biomarkers are used to predict the disease progression in the early stages and improve the assessment of therapeutic efficacy in these diseases in future clinical trials.


Market Analysis

Market Analysis and Insights of Dementia Alzheimer Disease Market
The Dementia - Alzheimer disease market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 10% in the above mentioned forecast period.
Dementia is a common term for a decline in mental ability harsh enough to obstruct with daily life. Alzheimer's is the most common cause of dementia. Dementia defines various numbers of symptoms which includes memory loss and problems with thinking, problem-solving or language.
The rise in prevalence of Alzheimer’s across the globe is amongst the important factor expected to intensify the growth and demand of dementia - Alzheimer disease market. In addition, the rise in geriatric population and increase in awareness regarding neurodegenerative diseases in developing countries are also expected contribute to the growth in the global market over the forecast period of 2021 to 2028. Also the strong pipeline of innovative treatment options and huge healthcare spending are also likely to enhance the growth of the market. Furthermore, the high demand for personalized drugs and affordable diagnostics tests are also one of the significant factors expected to fuel the growth of the dementia - Alzheimer disease market.   
The increase in research and development activities in disease modifying drugs and rapid surge in investment by major key players in the clinical studies of advanced treatment options are anticipated to offer significant growth opportunities for the market in the forecast period of 2021 to 2028.
However, the high cost of advanced treatments and various side-effects associated with certain treatments are expected to curb the growth of the dementia - Alzheimer disease market, whereas the high cost of prospective drugs can challenge the growth of the dementia - Alzheimer disease market.


Past conferences report

Conference series LLC takes a great honor in announcing the commencement of 11th International Conference on Alzheimer’s disease and Dementia on May 24-25, 2018 at Vienna, AustriaEuro Dementia 2018 has received a benevolent response from all over the world..
The conference witnessed an amalgamation of peerless speakers, who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Neuroscience. The eminent personalities at the conference were Don Kulasiri, Lincoln University, New Zealand, V R Badrakalimuthu, Parklands Hospital, UK, Manabu Tamura, Ministry of Economy, Trade and Industry, Japan, Arturo Solís Herrera, Human Photosynthesis® Research Centre, Mexico, Li Zeng, National Neuroscience Institute, Singapore, Nedim Ongun, Burdur State Hospital, Turkey, Ying Wang, China Pharmaceutical University, China, Mario Durán-Prado, University of Castilla-La Mancha, Spain, Santosh Bangar, MIND Clinic for Senior Citizens, India
Conferenceseries LLC offers its heartfelt appreciation to all the Organizing Committee Members, Chairs and Co-Chairs, Speakers, Students, Media Partners and Editorial Board Members of Journal of Alzheimer’s Disease & Parkinsonism, Journal of Neurology & Neurophysiology and Journal of Neurology and Neuroscience who supported the conference in every aspect for the awe-inspiring exhibition at the venue.
We once again thank you all for the enormous exquisite response. This inspires us to continue organizing events and conferences for furthering the neuroscience research. Conference series LLC therefore, is glad to announce its 15th International Conference on Dementia and Alzheimers Disease scheduled during March 25-26, 2019 at Osaka, Japan. Mark your calendars for the upcoming meeting.
We are hoping to see you soon!
5th International Conference on Alzheimer’s Disease & Dementia was organized during September 29-October 01, 2016 at Hilton London Heathrow Airport, London, UK with the support and contribution of the Organizing Committee Members.
All the participants were awarded with 5.25 AMA PRA Category 1 CreditsTM
Firstly we must thank you for trusting us and participating at Dementia 2016, a global platform to discuss various important aspects of Alzheimer’s disease, Dementia and Neurological disorders.
Keynote speakers:
Claude M Wischik, TauRx Therapeutics, UK
Jerzy Leszek, Wroclaw Medical University, Poland
Jordan L Holtzman, University of Minnesota, USA
Linda Levine Madori, St Thomas Aquinas College, USA
The conference witnessed an amalgamation of peerless speakers, Keynote sessions, workshops, symposium well-known researchers and delegates who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Neurology, Alzheimer’s disease and Dementia through their fabulous presentations at the podium of Dementia 2016. So as a continuation of Dementia 2016, we would like to heartily invite you to our upcoming 10th World Congress on Alzheimer’s disease and Dementia” during May 30-31, 2018 in Osaka, Japan.
All accepted abstracts have been indexed in the supporting Journals as a special issue. Conference Series felicitated all the Organizing Committee Members who enthusiastically participated in the conference and made this meeting a huge success.
We would like to proudly announce “10th World Congress on Alzheimer’s Disease and Dementia” during May 30-31, 2018 in Osaka, Japan.
We wish to pioneer a way to another outstanding event in the Osaka.
25th World Congress on Neurology & Neuroscience was organized during June 18-19, 2018 at Dublin, Ireland with the support and contribution of the Organizing Committee Members; we successfully hosted the event at the conference venue.
The conference was organized around the theme “Novel Therapies in Neurosciences and Neurological Disorders”. The event implanted a firm relation of upcoming strategies in the field of Neurology with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations. Hilary McDonagh , Sligo College of Further Education, Ireland was the moderator of Neuroscience Congress 2018. We are much thankful to Randall E. Merchant for his great support and help.
The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following Speakers were highlighted as Keynote speakers Patricia A. Quigley, Nurse Consultant LLC, USA; Char-Nie Chen, Chinese University of Hong Kong, Hong Kong; Natallia HalinouskayaGomel State Medical University, Belarus;  Gabriele Saretzki, University of Newcastle upon Tyne, UK; Hebah Hefzy, Henry Ford Hospital, The Weizmann Institute of Science, Israel, Hilary McDonagh, Sligo College of Further Education, Ireland. The conference witnessed an amalgamation of peerless speakers, Keynote speakers, well-known researchers and delegates who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Neurology through their fabulous presentations at the podium of Neuroscience Congress 2018.
Conferenceseries LLC offers its heartfelt appreciation to all the Organizing Committee Members, Chairs and Co-chairs, Speakers, Students, Media Partners and Editorial Board Members of Journal of Neurology & Neurophysiology, International Journal of Neurorehabilitation and Journal of Neurological Disorders who supported the conference in every aspect for the awe-inspiring exhibition at the venue.
Conference Series takes a significant privilege in reporting the beginning of eleventh World Congress on Neurology March 15-17, 2018 London, UK. This has been led with the point and the unmitigated plan of advancing the improvements of new recognitions and thoughts for investigating the abnormal state of learning come to by academic network on Neuroscience..
The gathering was sorted out around the topic scientific mission to upgrade the intriguing and perplexed Neurons. The occasion embedded a firm connection of up and coming systems in the field of Neurology with established researchers. The calculated and appropriate information shared, will likewise cultivate hierarchical coordinated efforts to sustain logical increasing speeds.
The gathering saw an amalgamation of excellent speakers, who illuminated the group with their lucky research information and on different charming points identified with the field of Neuroscience. The famous identities at the gathering were Harish C Pant, National Institutes of Health, USA, Evelyn M Garcia, Carilion Clinic, USA, Anthony E Kline, University of Pittsburgh, USA, David E Vance, and University of Alabama at Birmingham
Conference Series offers its ardent thankfulness to all the Organizing Committee Members, Chairs and Co-Chairs, Speakers, Students, Media Partners and Editorial Board Members of Journal of Neurology and Neurophysiology, Journal of Neuroinfectious Diseases and Journal of Neurological Disorders who bolstered the meeting in each angle for the stunning show at the setting.
We by and by thank all of you for the huge impeccable reaction. This motivates us to keep sorting out occasions and gatherings for advancing the Neuroscience Research. Conference Series in this way, is happy to report its 31st World Congress on Neurology & Neuroscience from March 25-26, 2019 Osaka, Japan.


To Collaborate Scientific Professionals around the World

Conference Date October 20-21, 2021

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Journal of Neurology and Neuroscience Journal of Neuropsychiatry Journal of Alzheimers Disease & Parkinsonism

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by